Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Real-world use of loncastuximab tesirine in heavily pretreated and high risk relapsed/refractory large B-cell lymphoma patients: German multicenter analysis

Evgenii Shumilov, Débora-Michèle Grote Urtubey, Marcel Teichert, Maximilian Seib, Rebecca Wurm-Kuczera, Joseph Kauer, Friedrich-Linus Roessiger, Tobias Tix, Alexander Hölscher, Philipp Gödel, Christoph Brey, Paolo Mazzeo, Zoi Saxonis, Belana Kuhn, Vanja Zeremski, Franziska Brunner, Susanne Ghandili, Enver Aydilek, Markus Maulhardt, Philipp Nakov, Gregor Friedrich, Christian Schultze-Florey, Giuliano Filippini Velazquez, Igor Age Kos, Anna Ossami Saidy, Christoph Kimmich, Maika Klaiber-Hakimi, Philipp Berning, Andrea Kerkhoff, Bertram Glass, Isabelle Krämer, Lorenz Thurner, Mathias Lutz, Florian Heidel, Vladan Vucinic, Christiane Pott, Andreas Viardot, Gerald Wulf, Thomas Weber, Dimitrios Mougiakakos, Francis Ayuk, Udo Holtick, Sascha Dietrich, Niklas Gebauer, Ulf Schnetzke, Mathias Hänel, Martin Dreyling, Peter Dreger, Björn Chapuy, Fabian Müller, Bastian von Tresckow, Georg Lenz

Blood (2025) 146 (Supplement 1): 5473.

https://doi.org/10.1182/blood-2025-5473

Published: 2025

Journal Articles

A Study on Experimentally Induced Thrombus Formation in JAK2-V617F and Calr-del52 Mouse Models Using Ligation of the Inferior Vena Cava (IVC)

Vikas Bhuria, Martin Böttcher, Vanja Zeremski, Andreas Müller, Dimitrios Mougiakakos, Thomas Fischer

Blood (2024) 144 (Supplement 1): 4521.

https://doi.org/10.1182/blood-2024-210931

Published: 2024

Journal Articles

Proteomic Profiling and Cytokine Analysis Reveals Molecular Signatures and Inflammatory Factors Associated with Thrombosis in JAK2-V617F Positive Myeloproliferative Neoplasm (MPN) Cohorts

Vikas Bhuria, Marco van Ham, Katrin Vogel, Ana Waldleben, Vanja Zeremski, Martin Böttcher, Monika Brunner-Weinzierl, Dimitrios Mougiakakos, Burkhart Schraven, Lothar Jänsch, Thomas Fischer

Blood (2023) 142 (Supplement 1): 6340.

https://doi.org/10.1182/blood-2023-174835

Published: 2023

Journal Articles

JAK2-V617F Promotes up-Regulation of Pro-Inflammatory Cytokines Including IL-1 upon Adhesion-Induced Activation of β1/β2 Integrins

Conny K. Baldauf, Emmanouil Charakopoulos, Martin Böttcher, Vanja Zeremski, Dimitrios Mougiakakos, Burkhart Schraven, Thomas Fischer

Blood (2023) 142 (Supplement 1): 2749.

https://doi.org/10.1182/blood-2023-174058

Published: 2023

Journal Articles

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

Blood (2021) 138 (Supplement 1): 4533.

https://doi.org/10.1182/blood-2021-153200

Published: 2021

Journal Articles

Comparison of Clinical Features and Outcomes in Patients with Primary Central Nervous System Lymphoma Treated within and Outside a Clinical Trial: A Retrospective Study

Vanja Zeremski, Thomas Fischer, Enrico Schalk

Blood (2017) 130 (Supplement 1): 1565.

https://doi.org/10.1182/blood.V130.Suppl_1.1565.1565

Published: 2017

Journal Articles

the Monosomal Karyotype Is an Independent Predictor of Poor Survival and Risk of AML Transformation in Patients with Myelodysplastic Syndrome

Aleksandar Savic, Dragomir Marisavljevic, Natasa Stanisavljevic, Ivana Milosevic, Vanja Zeremski, Nada Vlaisavljevic, Marina Dragicevic

Blood (2014) 124 (21): 5613.

https://doi.org/10.1182/blood.V124.21.5613.5613

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-world use of loncastuximab tesirine in heavily pretreated and high risk relapsed/refractory large B-cell lymphoma patients: German multicenter analysis

A Study on Experimentally Induced Thrombus Formation in JAK2-V617F and Calr-del52 Mouse Models Using Ligation of the Inferior Vena Cava (IVC)

Proteomic Profiling and Cytokine Analysis Reveals Molecular Signatures and Inflammatory Factors Associated with Thrombosis in JAK2-V617F Positive Myeloproliferative Neoplasm (MPN) Cohorts

JAK2-V617F Promotes up-Regulation of Pro-Inflammatory Cytokines Including IL-1 upon Adhesion-Induced Activation of β1/β2 Integrins

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

Comparison of Clinical Features and Outcomes in Patients with Primary Central Nervous System Lymphoma Treated within and Outside a Clinical Trial: A Retrospective Study

the Monosomal Karyotype Is an Independent Predictor of Poor Survival and Risk of AML Transformation in Patients with Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Update search

Real-world use of loncastuximab tesirine in heavily pretreated and high risk relapsed/refractory large B-cell lymphoma patients: German multicenter analysis

A Study on Experimentally Induced Thrombus Formation in JAK2-V617F and Calr-del52 Mouse Models Using Ligation of the Inferior Vena Cava (IVC)

Proteomic Profiling and Cytokine Analysis Reveals Molecular Signatures and Inflammatory Factors Associated with Thrombosis in JAK2-V617F Positive Myeloproliferative Neoplasm (MPN) Cohorts

JAK2-V617F Promotes up-Regulation of Pro-Inflammatory Cytokines Including IL-1 upon Adhesion-Induced Activation of β1/β2 Integrins

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

Comparison of Clinical Features and Outcomes in Patients with Primary Central Nervous System Lymphoma Treated within and Outside a Clinical Trial: A Retrospective Study

the Monosomal Karyotype Is an Independent Predictor of Poor Survival and Risk of AML Transformation in Patients with Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only